DOC earnings analysis
What we found in DOC's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Healthpeak Properties, Inc. delivered a strong Q1 2026 performance with revenue reaching $752.95 million, which was a notable increase of 9.5% from the estimated revenue while EPS surpassed expectations at $0.45 compared to a loss of $0.17 in the same quarter last year. Management highlighted positive trends from recent acquisitions and an IPO, indicating solid growth prospects moving forward.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue Growth Exceeds Estimates
- Reported revenue for Q1 2026 was $752.95 million, 9.5% higher than the estimated $688.89 million.
- Earnings Per Share Beat Expectations
- EPS for Q1 2026 was $0.45, exceeding the estimated $0.43 and a significant increase from $0.06 in Q1 2025.
- Significant Increase in Net Income
- Net income applicable to common shares rose to $193.48 million from $42.36 million YoY.
- Strong Performance in Outpatient Medical Segment
- Outpatient medical Adjusted NOI increased by 2.4%, contributing $186.84 million.
- Successful Janus Living IPO Contribution
- Janus Living IPO generated gross proceeds of $966 million, enhancing liquidity and growth potential.
- Improved Senior Housing Performance
- Senior housing Adjusted NOI increased by 13.8%, reaching $55.43 million due to increased resident fees.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Increased Interest Expense
- Interest expense rose to $87.29 million from $72.69 million, straining profitability due to higher borrowings.
- Decreased NOI from Lab Sector
- Lab Adjusted NOI decreased by 7.2% to $112.94 million, primarily due to lower occupancy.
- Transaction Costs Related to IPO
- Transaction costs surged to $24.15 million from $5.53 million, impacting overall expenses significantly.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $0.45
- Segment
- Outpatient Medical
- Segment
- Lab
- Segment
- Senior Housing
What they said about what is next.
Management anticipates FY 2026 diluted EPS in the range of $0.46 to $0.50, up from prior guidance.
The filing reads better than the one before it.
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing DOC makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever